NCT04685876View on ClinicalTrials.gov

Comparing TAP Blocks Bupivacaine, and Placebo for Plane

PHASE3CompletedINTERVENTIONAL
Enrollment

285

Participants

Timeline

Start Date

June 4, 2021

Primary Completion Date

February 20, 2024

Study Completion Date

February 20, 2024

Conditions
Abdominal Surgery
Interventions
DRUG

Liposomal bupivacaine

4-quadrant TAP block with liposomal bupivacaine

DRUG

Plain bupivacaine

4-quadrant TAP block with plain bupivacaine

DRUG

Normal saline

placebo (normal saline).

Trial Locations (1)

44195

Cleveland Clinic, Cleveland

All Listed Sponsors
lead

Edward Mascha

OTHER